📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. (2023)

First Author: Lambertini M

Attributed to: MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6004/jnccn.2022.7065

PubMed Identifier: 36634607

Publication URI: http://europepmc.org/abstract/MED/36634607

Type: Journal Article/Review

Volume: 21

Parent Publication: Journal of the National Comprehensive Cancer Network : JNCCN

Issue: 1

ISSN: 1540-1405